Imunon, Inc. Net Income Loss

• Imunon, Inc. showed an increase of +22.2% in Net Income Loss from 2024 to 2025.
• This data is from Imunon, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: -$2.63 million | Q3 2010: -$4.72 million | Q1 2011: -$3.76 million | Q2 2011: -$6.94 million | Q3 2011: -$6.39 million | Q1 2012: -$6.19 million | Q2 2012: -$6.10 million | Q3 2012: -$6.02 million | Q1 2013: -$651.0 thousand | Q2 2013: $420.9 thousand | Q3 2013: -$4.07 million | Q1 2014: -$5.42 million | Q2 2014: -$6.67 million | Q3 2014: -$6.94 million | Q4 2014: -$6.46 million | Q1 2015: -$7.01 million | Q2 2015: -$5.67 million | Q3 2015: -$4.27 million | Q4 2015: -$5.51 million | Q1 2016: -$5.72 million | Q2 2016: -$4.53 million | Q3 2016: -$6.41 million | Q1 2017: -$5.16 million | Q2 2017: -$5.67 million | Q3 2017: -$5.67 million | Q1 2018: -$4.48 million | Q2 2018: -$8.23 million | Q3 2018: -$4.66 million | Q1 2019: -$2.37 million | Q2 2019: -$5.90 million | Q3 2019: -$5.48 million | Q1 2020: -$5.06 million | Q2 2020: -$5.34 million | Q3 2020: -$8.07 million | Q1 2021: -$5.69 million | Q2 2021: -$5.45 million | Q3 2021: -$5.41 million | Q1 2022: -$10.47 million | Q2 2022: -$6.04 million | Q3 2022: -$6.15 million | Q1 2023: -$5.59 million | Q2 2023: -$5.56 million | Q3 2023: -$3.48 million | Q1 2024: -$4.93 million | Q2 2024: -$4.79 million | Q3 2024: -$4.85 million | Q1 2025: -$4.10 million | Q2 2025: -$2.74 million | Q3 2025: -$3.43 million.
• Over the full 17 years of available data (2010 to 2025), Imunon, Inc.'s Net Income Loss has grown by 23.0%.
• Historical annual values: Fiscal year 2025: -$14.50 million | Fiscal year 2024: -$18.62 million | Fiscal year 2023: -$19.51 million | Fiscal year 2022: -$35.90 million | Fiscal year 2021: -$20.77 million | Fiscal year 2020: -$21.48 million | Fiscal year 2019: -$16.85 million | Fiscal year 2018: -$11.88 million | Fiscal year 2017: -$20.40 million | Fiscal year 2016: -$22.05 million | Fiscal year 2015: -$22.46 million | Fiscal year 2014: -$25.49 million | Fiscal year 2013: -$8.25 million | Fiscal year 2012: -$26.57 million | Fiscal year 2012: -$26.57 million | Fiscal year 2011: -$23.22 million | Fiscal year 2010: -$18.82 million.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026